| CPR included in the 2014 survey | CPR included in the current survey | Current guideline recommending CPR |
|---|---|---|
| Cardiovascular disease risk | ||
| JBS2 risk charts or calculator67 | JBS3 risk calculator68 | JBS’ consensus recommendations for the prevention of cardiovascular disease (JBS3)68 |
| QRISK or QRISK269,70 | QRISK2 or QRISK370,71 | NICE clinical guideline CG181: Cardiovascular disease: risk assessment and reduction, including lipid modification36 |
| ASSIGN score72 | ASSIGN score72 | SIGN 149: Risk estimation and the prevention of cardiovascular disease37 |
| UKPDS risk engine73 | UKPDS risk engine73 | — |
| SCORE risk charts74 | SCORE risk charts74 | 2016 European guidelines on cardiovascular disease prevention in clinical practice42 |
| PROCAM score75 | PROCAM score75 | — |
| Framingham risk scores76 | Framingham risk scores76 | — |
| — | ACC/AHA pooled cohort equation32 | 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease34 |
| New Zealand tables77 | New Zealand tables77 | — |
| — | New Zealand primary prevention equations33 | New Zealand Ministry of Health: Cardiovascular disease risk assessment and management for primary care 201835 |
| — | WHO/ISH risk prediction charts78 | WHO: Prevention of cardiovascular disease47 |
| Stroke and venous thromboembolisma | ||
| ABCD or ABCD2 79,80 | ABCD2, ABCD3, or ABCD3-I score80,81 | NICE clinical guideline CG68: Stroke and transient ischaemic attack in over 16 seconds: diagnosis and initial management82 |
| California score83 | California score83 | — |
| CHADS or CHADS2 84 | CHADS2 or CHA2DS2-VASc score84,85 | NICE clinical guideline CG180: Atrial fibrillation: management;38 SIGN 129: Antithrombotics: indications and management;39 and 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS43 |
| — | HAS-BLED score86 | NICE clinical guideline CG180: Atrial fibrillation: management38 |
| Wells scores for deep vein thrombosis87 | Wells scores for deep vein thrombosis87 | NICE clinical guideline CG144: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing;40 and SIGN 122: Prevention and management of venous thromboembolism41 |
| Wells score for pulmonary embolism88 | Wells scores for pulmonary embolism88 | NICE clinical guideline CG144: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing;40 and SIGN 122: Prevention and management of venous thromboembolism41 |
| — | Geneva or revised Geneva score89,90 | 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism;44 and SIGN 122: Prevention and management of venous thromboembolism41 |
| — | Pulmonary Embolism Severity Index (PESI) or simplified Pulmonary Embolism Severity Index (sPESI)91,92 | 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism45 |
aThese CPRs were included under the ’General Medical’ category in the 2014 survey. ACC/AHA = American College of Cardiology/Amercian Heart Association. CPR = clinical prediction rule. ESC = European Society of Cardiology. ISH = International Society of Hypertension. JBS = Joint British Societies. NICE = National Institute for Health and Care Excellence. SIGN = Scottish Intercollegiate Guidelines Network. WHO = World Health Organization.